Abstract
Allergic rhinitis diagnosis is more likely in older patients, females, White patients, non‐Hispanic patients, those with higher education (both high school and college), those with higher socioeconomic status, and those with health insurance. At the same time, oral antihistamine and nasal steroid medications listed in the health record are more likely among Black patients and those with lower income levels. These results highlight the barriers to allergic rhinitis diagnoses and treatment, and need for providers to ensure that underserved patients are offered appropriate care.